{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:21:55Z","timestamp":1783362115191,"version":"3.54.6"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T00:00:00Z","timestamp":1335916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically review all cases in the literature of erosion associated with Atrial Septal Defect (ASD) occluder devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Delayed erosion of the aortic or atrial wall is an infrequent but potentially lethal complication of percutaneous septal defect closure using an ASD device. The epidemiology is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The MEDLINE database was searched for cases of ASD occluder device\u2010associated erosion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty\u2010five articles present erosion events associated with the AMPLATZER\u2122 Septal Occluder (ASO) device (March 2002\u2013June 2011), documenting 21 independent, surgically confirmed cases. Another 79 distinct events are reported in case series and review articles. Of all identified independent cases, 73 were reported in the United States. No articles associate the HELEX\u2122 Septal occluder and erosions. Additional events are reported in association with FDA\u2010unapproved percutaneous defect closure devices (\n                      <jats:italic>n<\/jats:italic>\n                      = 16). Estimation of ASO erosion incidence is unreliable because the numerator (number of erosion events) and denominator (number of patients with an implanted device) are unknown; estimates range from 0.1 to 0.3%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cardiac erosion is a rare but serious complication of the ASO device. Erosion events are most often ascribed to device over\u2010sizing or deficient retro\u2010aortic rims; however, both consensus and evidence for a cogent risk factor(s) is lacking. Further assessment of the root cause of erosion and true incidence of this complication is required; analyses using control patients and\/or device registry establishment represent logical next steps. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ccd.24347","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T15:37:46Z","timestamp":1335973066000},"page":"157-167","source":"Crossref","is-referenced-by-count":111,"title":["Percutaneous atrial Septal Occluder devices and cardiac erosion: A review of the literature"],"prefix":"10.1002","volume":"80","author":[{"given":"Geoffrey B.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G.","family":"Brindis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Mansalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,2]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"United States Food and Drug Administration. Available at:http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P000039a.pdf. Accessed August 9 2011."},{"key":"e_1_2_6_3_2","unstructured":"United States Food and Drug Administration. Available at:http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf5\/P050006a.pdf. Accessed August 9 2011."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10047-011-0576-6"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.10.076"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2011.03.006"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.06.016"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2009.12.021"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2009.06.013"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21931"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.02.032"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3282f329e8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-3-25"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21145"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2007.00107.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0825"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.08.008"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.08.013"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.08.012"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20436"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.03.098"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2004.100669"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.12.072"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)00901-9"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20211"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10434"},{"key":"e_1_2_6_27_2","first-page":"479","article-title":"Perforation of the aorta after percutaneous closure of an atrial septal defect with an Amplatz prosthesis, presenting with acute severe hemolysis","volume":"95","author":"Aggoun Y","year":"2002","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0742-2822.2004.04062.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22081"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8191.2007.00510.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21963"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22470"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10371"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.02.057"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21582"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.08.002"},{"key":"e_1_2_6_37_2","first-page":"37","article-title":"Percutaneous closure of patent foramen ovale: preliminary experience with the PFO Star","volume":"97","author":"Stauffer JC","year":"2004","journal-title":"[Article in French] Arch Mal Coeur Vaiss."},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.11.001"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2006.00125.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8191.2007.00483.x"},{"key":"e_1_2_6_41_2","first-page":"E39","article-title":"Interatrial septal closure devices and aortic perforation: a note of caution","volume":"21","author":"Schoen SP","year":"2009","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.09.079"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21339"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2008.00763.x"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2008.00421.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2007.10.013"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.2143\/AC.60.5.2004973"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22103"},{"key":"e_1_2_6_49_2","unstructured":"CarrollJ. World Wide Analysis of Tissue Erosion and ASO. Presented at: Transcatheter Cardiovascular Therapeutics November 7\u201311 2011."},{"key":"e_1_2_6_50_2","unstructured":"Available at:https:\/\/www.ncdr.com\/webncdr\/DefaultCathPCI.aspx. Accessed September 29 2011."},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1633"},{"key":"e_1_2_6_52_2","unstructured":"Food and Drug Administration. Information for physicians and patients on the withdrawal of two humanitarian device exemptions (HDEs) For Patent Foramen Ovale (PFO) Occluders. Available at:http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/HowtoMarketYourDevice\/PremarketSubmissions\/HumanitarianDeviceExemption\/ucm135747.htm. Last accessed August 18 2011."}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.24347","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.24347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:20:56Z","timestamp":1700583656000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.24347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1002\/ccd.24347"],"URL":"https:\/\/doi.org\/10.1002\/ccd.24347","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722746532.793539052","asserted-by":"object"}]},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,2]]}}}